Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Breast Cancer Research : BCR|June 10, 2003
Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitizationJulia M W Gee, Robert I Nicholson
Endocrine-Related Cancer|August 23, 2005
Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X modelCindy M Staka, Robert I Nicholson, Julia M W Gee
Journal of Biomechanics|May 22, 2009
Prestressing in finite deformation abdominal aortic aneurysm simulationM W Gee, C Reeps, H H Eckstein, et al.
Biomechanics and Modeling in Mechanobiology|February 10, 2010
Impact of calcifications on patient-specific wall stress analysis of abdominal aortic aneurysmsA Maier, M W Gee, C Reeps, et al.
International Journal for Numerical Methods in Biomedical Engineering|February 6, 2016
Computational evaluation of aortic occlusion and the proposal of a novel, improved occluder: Constrained endo-aortic balloon occlusionM H de Vaal, M W Gee, U A Stock, et al.
Endocrine-Related Cancer|December 23, 2004
Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapyR I Nicholson, C Staka, F Boyns, et al.
Pharmaceutical Research|July 16, 2008
In vitro effects on MCF-7 breast cancer cells of signal transduction inhibitor/tamoxifen/eicosapentaenoic acid combinations and their simultaneous delivery across skinZoë Davison, Carol Dutkowski, Julia M W Gee, et al.
Breast Cancer Research and Treatment|September 21, 2004
Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cellsNicola J Jordan, Julia M W Gee, Denise Barrow, et al.
Endocrine-Related Cancer|August 23, 2005
Overview of tyrosine kinase inhibitors in clinical breast cancerA Agrawal, E Gutteridge, J M W Gee, et al.
Exploration of Targeted Anti-Tumor Therapy|May 20, 2022
The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancerSamuel Jones, Georgia Farr, Thirayost Nimmanon, et al.
Pageof 7